Skip to main content
OpenTrials
Completed

NCT Number: NCT02961361

the Effect of Dexmedetomidine in Coracoid Approach Brachial Plexus Block

Dexmedetomidine is an α-2 adrenoreceptor agonist and has been extensively used through intravenous infusion,in order to improved the quality of block in regional anesthesia. In this prospective, randomized study, the authors focus on the effect of dexmedetomidine mixed with ropivacaine in coracoid approach brachial plexus block.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–60 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 4

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • American Society of Anesthesiologists (ASA) physical status I or II;
  • Aged 18-60 years;
  • The elbow, forearm, wrist or hand surgery

Exclusion criteria

  • History of allergy to local anesthetics;
  • Coagulation dysfunction, neuromuscular disease or local infection;
  • The operation time is longer than the local anesthetics effective time.

Treatment and study plan

Ropivacaine

Drug

40 ml 0.375% ropivacaine was injected after Locating brachial plexus.

ropivacaine mixed with dexmedetomidine

Drug

40 ml 0.375% ropivacaine mixed with dexmedetomidine was injected after Locating brachial plexus.

Primary outcomes

  1. duration time

    Time frame: once per hour after surgery until 24 hours after surgery

    effective analgesia time

Secondary outcomes

  1. onset time

    Time frame: 5,10,15,20,25,30 min after injection

  2. Visual analogue scale

    Time frame: 2,6,12,24hour after injection

Sponsors and collaborators

Lead sponsor

The First Hospital of Qinhuangdao

Other Gov

Registry information

Important dates

Study start
2016
Primary completion
2017
Study completion
2017
First posted
Nov 11, 2016
Registry last updated
Feb 15, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.